GSK Settlement: Changing The Way Drug Cos. Do Business?

Law360, New York (July 12, 2012, 1:52 PM EDT) -- On July 2, 2012, the U.S. Department of Justice announced the largest health care fraud settlement in U.S. history: GlaxoSmithKline LLC  will pay $3 billion to resolve criminal and civil allegations of unlawfully promoting prescription drugs, failing to report safety data and engaging in allegedly false price reporting practices. This resolution includes a criminal fine and forfeiture totaling $1 billion and $2 billion in civil payments.

Historically Severe Criminal and Civil Fines

Under the Food, Drug and Cosmetic Act (“FDCA”), GSK may promote its prescription drugs...
To view the full article, register now.